IMR Press / RCM / Special Issues / 1635473063504

Cardiovascular Health and COVID-19

Submission deadline: 30 July 2022
Special Issue Editor
Alpo Vuorio, MD
Mehiläinen Airport Health Centre, University of Helsinki, Department of Forensic Medicine, Helsinki, Finland
Interests: COVID-19; Endothelial dysfunction; cardiovascular health; Lipoprotein A; Blood component removal; Proprotein convertase 9; Pilots; Familial hypercholesterolemia
Special Issue Information

Dear Colleagues,

Several studies have shown that patients with existing cardiovascular diseases who develop SARS-CoV-2 infections have a poor prognosis; especially those presenting with an acute myocardial injury, in whom mortality is increased. In addition, existing coronary artery disease is a significant risk factor for acute myocardial infarction among patients with SARS-CoV-2 infection. The COVID-19 pandemic has made it more difficult for cardiovascular physicians to deliver optimal care for heart patients, and there have been delays in treatment. There is also a concern regarding the long-term effects of the COVID-19 pandemic in patients with and those that develop cardiovascular diseases, which may contribute to increased morbidity and mortality. The role of prevention, including effective cholesterol lowering medication, is essential. In addition, the role of ACE2 receptors and endothelial dysfunction is under intensive investigation to determine the vascular pathogenesis of the SARS-CoV-2 infection.

This Special Issue welcomes original research articles, opinion articles and reviews related to all aspects of cardiovascular health and COVID-19.

Prof. Dr. Alpo Vuorio

Guest Editor

Acute myocardial injury
Coronary artery disease
Cardiovascular disease
Endothelial dysfunction
Manuscript Submission Information

Manuscripts should be submitted via our online editorial system at by registering and logging in to this website. Once you are registered, click here to start your submission. Manuscripts can be submitted now or up until the deadline. All papers will go through peer-review process. Accepted papers will be published in the journal (as soon as accepted) and meanwhile listed together on the special issue website. Research articles, reviews as well as short communications are preferred. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office to announce on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts will be thoroughly refereed through a double-blind peer-review process. Please visit the Instruction for Authors page before submitting a manuscript. The Article Processing Charge (APC) in this open access journal is 2200 USD. Submitted manuscripts should be well formatted in good English.

Planned Paper (3 Papers)
The below list represents only planned manuscripts. Some of these manuscripts have not been received by the Editorial Office yet. Papers submitted to IMR Press journals will subject to peer-review before acceptance

Cardiac Injury in COVID-19: A Systematic Review of Relevant Meta-Analyses

Trontzas I et al.

ST-Segment Elevation Myocardial Infarction (STEMI) Management in The Era of COVID-19: A Systematic Review of Published Guidance Reports

Trontzas I et al.

Familial Hypercholesterolemia Patients and COVID-19 - Not to be Neglected

Alpo Vuorio et al.

Published Paper (3 Papers)
Open Access Original Research
The impact of anxiety level on decision to seek medical care of non-COVID cardiac patients during the pandemic outbreak—single-center experience in Israel
Ofir Koren, Saleem Abu Rajab, Mohammad Barbour, Moriah Shachar, ... Einat Mader
Rev. Cardiovasc. Med. 2022, 23(2), 50;
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Open Access Original Research
Enoxaparin dose impacts blood cell phenotypes during mild SARS-CoV-2 infection: the observational single-center study
Liudmila Buryachkovskaya, Nikita Lomakin, Arthur Melkumyants, Julia Docenko, ... Victor Serebruany
Rev. Cardiovasc. Med. 2021, 22(4), 1685–1691;
(This article belongs to the Special Issue Cardiovascular Health and COVID-19)
Back to top